Skip to main content
. 2012 Jan;87(1):67–76. doi: 10.1016/j.mayocp.2011.09.001

FIGURE 3.

FIGURE 3

Treatment algorithm. aCladribine preferred because of its ease of administration, favorable toxicity profile, and higher complete response rates. bIndicates consider switching to other purine analog given lack of cross-resistance. HCL = hairy cell leukemia.